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Pulmonary alveolar microlithiasis is a disorder in which many tiny fragments (microliths) of calcium
phosphate gradually accumulate in alveoli. Loss of function mutations in the gene SLC34A2 coding for the
sodium phosphate co-transporter (NaPi-IIb) are responsible for genetic forms of alveolar microlithiasis.
We now report a consanguineous Italian family from Calabria with two affected members segregating
alveolar microlithiasis in a recessive fashion. We describe, for the ﬁrst time, a novel loss of function
mutation in the gene coding for NaPi-IIb. A careful description of the clinical phenotype is provided
together with technical details for direct sequencing of the gene.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Two protein families, SLC20 and SLC34, act as Naþ-dependent,
secondary-active co-transporters to transport Pi across cell mem-
branes [1].
The SLC20 family has two members, SLC20A1 (also known as
PiT-1, OMIM *137570) and SLC20A2 (also known as PiT-2 OMIM:
*158378, #213600 AD). Both proteins are ubiquitous and consid-
ered as “housekeeping” transport protein. PiT-1 and PiT-2 are
electrogenic [2]. The importance of these channels is highlighted by
their tissue-speciﬁc activity, regulatory pathways, and by the pa-
thology associated with genetic variants [3]. The SLC34 family hasnce in man; AD, Autosomic
eterozygous; Hsa, Homo sa-
riodic acid-Schiff.
rotti@unicz.it (N. Perrotti).
Ltd. This is an open access article uthree members: SLC34A1, coding for NaPi-IIa, OMIM: (*182309,
#613388 AR #612286 AD), SLC34A2, coding for NaPi-IIb, OMIM:
(*624217, #265100 AR), and SLC34A3, coding for NaPi-IIc OMIM:
(*609826, #241530 AD/CH). These transporters mediate the trans-
location of one divalent inorganic phosphate (HPO4 (2-)) together
with two (NaPi-IIc) or three sodium ions (NaPi-IIa and NaPi-IIb),
respectively. Consequently, phosphate transport by NaPi-IIa and
NaPi-IIb is electrogenic whereas NaPi-IIc is electroneutral. NaPi-IIa
and NaPi-IIc are expressed mostly on the brush border membrane
of the proximal tubule [4]. Homozygous mutations in the gene
SLC34A2 coding for NaPi-IIb are responsible for pulmonary alveolar
microlithiasis, a rare disease characterized by the deposition of
calcium phosphate microliths throughout the lungs.2. Case report
Here we describe the case of a 58 years old lady reported for
genetic counseling by the unit of pneumology of our university
hospital.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Clinical examination revealed a regular facies. During ausculta-
tion of the lungs ﬁne expiratory crackles were heard on the whole
thorax and especially in the left basal part. Cardiac auscultationwas
normal, and no cyanosis or peripheral edema was observed. There
was no history of smoking or previously known pulmonary dis-
eases. On routine blood examination, blood count and serum
chemistry were found normal. Arterial blood gas analysis, ECG, and
echocardiography showed no important abnormalities. Pulmonary
function tests were also normal.
Radiologic ﬁndings are shown in Fig. 1.
Posteroanterior chest radiographs (Fig. 1A) depicted diffuse,
scattered, bilateral areas of micronodular pattern, producing a
“sandstorm” appearance, ﬁrst involving the inferior portions and
then middle and upper portions of the lungs [5,6].
Based on these ﬁndings, a high resolution computed tomogra-
phy scan was performed (Fig. 1BeC) that revealed a diffuse sym-
metric pattern of microlithiasis, consisting of both discrete nodules
and areas of ground glass attenuation of the lung parenchyma.
Calciﬁcations were also seen along the vessels, along with crazy
paving pattern areas.Multiple sub-pleural cysts were seen along the
costal and mediastinal pleura [7,8].
The patient underwent a bronchoscopy with bronchoalveolar
lavage, which produced numerous microliths in the bron-
choalveolar lavage liquid, compatible with a diagnosis of pulmo-
nary microlithiasis.
Ultrasound of abdomen showed moderate liver steatosis, a
sepimented cyst approximately 2.5 2 cm on the lower third of the
left kidney and a multinodular uterus.
Analysis of the pedigree revealed that our patient was the sister
of a woman affected by pulmonary alveolar microlithiasis (Fig. 2A).
We designed an optimized high speciﬁc sequencing primer set
(Table 1) for SLC34A2 gene coding exons using the NCBI platform,
AmpliFX bioinformatic software [9] and Repeat Masker web app
from the institute for Systems Biology [10].
SLC34A2 gene exons were sequenced on an AbiPrism 310 plat-
form. Our patient was homozygous for a novel frameshift deletion
in exon 3 (c.212_224 delACCTACCCACTCT pAsn71IlefsX25, Ref seq.
ENSG00000157765) that caused a frameshift resulting in a trun-
cated protein at codon 95 (Fig. 2B).
All the sons and daughter of our proband patient were hetero-
zygous for the maternal allele.Fig. 1. (A) Chest radiograph: symmetric pattern of diffuse ﬁne micronodules in both lung
discrete nodules and areas of ground glass attenuation of the lung parenchyma.3. Results
In the present study we summarize the actual ﬁndings of a
patient with familiar microlithiasis and describe a mutation in the
SLC34A2 gene, coding for NaPi-IIb, (GeneID: 10568). The mutation,
a frameshift mutation in the exon 3 (homozygote c.212_224
delACCTACCCACTCT (pAsn71IlefsX25)) that produces a truncated
form of the protein, was never reported before in the literature. In
this paper a new set of highly speciﬁc primers for coding exons of
the gene is proposed.
In 2003 and 2004 two monumental reviews were published,
detailing 424 cases [11] and 527 cases [5]. After those, mostly case
reports were published. Two recent reviews were published by
Tachibana et al. [12] and Ferreira et al. [13].
Pulmonary alveolar microlithiasis was found in the Hsa and in
other animal species such as dogs, cats, monkeys, birds, ﬁshes and
anphibians [5]. PAM is a rare condition, counting about 700 cases in
literature. Its geographic distribution is higher in Europe and in
Asia, counting together 73% of all cases [11] or 83% [5]. TheM:F ratio
is 1:1. It can be diagnosed from stillbirth to the VII decade. About
53% of patients present no symptoms on diagnosis. Some cases
survived even 44 years after ﬁrst diagnosis. The familiar form
represents around 32% [5] or 36% [11] of all cases.
NaPi-IIb is expressed mostly in type II pneumocytes, the cells
that produce the surfactant. Phospholipides are a fundamental
component of surfactant and when they degrade they lose Pi. Type
II pneumocytes are involved in the reabsorption of exhaust phos-
pholipides. If the ability to reabsorb Pi is altered in these cells, the
amount of Pi in the surfactant will raise and then precipitates, thus
forming the microlithes.
Microlithes will raise in volume and eventually come into con-
tact with the alveolar walls, starting a ﬁbrotic process.
The intra alveolar lamellar microlithes are PAS positive, formed
by concentric lamellae of Caþþ around a granular or amorphous
central core. They tend to have spherical or ovoid shape, a diameter
between 0.01 and 2.8 mm; Pi:Ca ratio of 1:2, compatible with
Calcium phosphate and/or hydroxylapatite [14, 15]. The features
above describe stones formed in familial pulmonary alveolar
microlithiasis, which are different from the ones caused by sporadic
pulmonary alveolar microlithiasis [16] and from the ones caused by
metastatic and dystrophic processes [13].
From a macroscopic point of view, the lungs of affecteds. (BeC) HRCT images: diffuse symmetric pattern of microlithiasis, consisting of both
Fig. 2. (A) Family pedigree. The proband (IV-2) is indicated by an arrow. (B) DNA sequences of SLC34A2, exon 3 from the homozygous proband and the heterozygous son V-5, as
indicated. The wild type sequence corresponds to NCBI NM_006424.
Table 1
Primers set for Hsa SLC34A2 coding exons.
CCCAGTTGATGCTTTGCAACCA SLC34A2 ex 2FOR
CCCAGTTGATGCTTTGCAACCA SLC34A2 ex 2REV
TTGTCTGCAGATCGGCCTTTGT SLC34A2 ex3 FOR
AGGACCCTTGCTTCAAGGGAATCA SLC34A2 ex3 REV
GCCAAACTTCTCAGGGTTTCCA SLC34A2 ex4 FOR
GAGAGGGCTTGCTGAGTTTTAC SLC34A2 ex4 REV
TTTACTCAGTGCCCACCTAATCCC SLC34A2 ex5 FOR
CAAGGCCTGGACATATTCAGAGTG SLC34A2 ex5 REV
GCATAGGTAACTTTAGCCTGCCTC SLC34A2 ex6 FOR
TAGCCATACCTCCCTGTGGTTACT SLC34A2 ex6 REV
TCACATGGTGCCCACTTGCTTA SLC34A2 ex7 FOR
TATATCTGTCAGCTCAGGTAGGGG SLC34A2 ex7 REV
GGATATGCTGATGGTTTCCTGTCT SLC34A2 ex8 FOR
CCTACTGTTTACCTGCATTTGGC SLC34A2 ex8 REV
ATACTGCATGCACCATGGG SLC34A2 ex9 FOR
CTGTCCTTTCCTTCACTTACTGGG SLC34A2 ex9 REV
GGCTGAGAAGGGCTGTCTTGATTT SLC34A2 ex10 FOR
CCACCCAGGATGCCAAGAACATTT SLC34A2 ex10 REV
GATGTACAACCTCACCCCTAAGCC SLC34A2 ex11 FOR
CTCAATGGTTATCACGCCGATTCC SLC34A2 ex11 REV
CACTGCCATTTCCTGTCATCCCAT SLC34A2 ex12 FOR
GTCCTGAAAACTTTACCGTGGCT SLC34A2 ex12 REV
TGATGCCTGCTAGCTTACCT SLC34A2 ex13.1 FOR
GGAAGTTCCAGTTCTGGAGT SLC34A2 ex13.1 REV
TCATCCTGGTACTGTGCCT SLC34A2 ex13.2 FOR
TCGCTAATGGGGAGCAAATC SLC34A2 ex13.2 REV
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serious cases, showing reduced elasticity and higher resistance.
External surfaces appear wrinkled, ruvid and irregular due to the
numerous microlithes. Apical bullae and blebs can be found on the
apexes and the forward portions of the lungs. Microlites were also
found in the sympathetic ganglia and in the gonads. calciﬁcations of
pericardium, epididymis, seminal vesicles and prostate were also
reported. In fact the expression of SLC20A2 has been demonstrated
in other cells, including enterocytes. In these cells the membrane
abundance of the channel is regulated by ubiquitin ligase Nedd4-2
and by serum- and glucocorticoid-dependent kinase 1 [17].
Under a clinical point of view a “clinical-radiological dissocia-
tion” has been described, where a very serious radiological situa-
tion is accompanied by a modest clinical condition. This condition
generally has a slow evolution, and it has been diagnosed in in-
dividuals of different age. Serum levels of surfactant proteins A and
D correlate with the progression of the disease, and may be a useful
monitoring tool [18].
Corticosteroids are generally considered to be ineffective, as
well as hydroxychloroquine and budesonide [19]. Long termetidronate treatment has been attempted in two patients and
resulted in some radiological beneﬁts [20]. Single or bilateral lung
transplantation is an option.
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